Novici Biotech Chair Named President of Integrated Biopharma Subsidiary
Robert Erwin has been named president of InB:Biotechnologies, a wholly owned subsidiary of Integrated Biopharma. Erwin will lead the implementation of InB’s plant-based vaccine and therapeutics strategy, and guide the development of InB as an independent company.
Erwin is the chairman of Novici Biotech, a private biotechnology company; and the co-founder, president and director of the Marti Nelson Cancer Foundation, which helps fund cancer support, advocacy and patient navigator programs.
He served as co-founder and chairman of Large Scale Biology from its founding in 1988 through 2003, including a successful initial public offering in 2000, and continued as non-executive chairman until 2006. He served as chairman of Icon Genetics from 1999 until its acquisition by a subsidiary of Bayer in 2006. Since then, Erwin served as managing director of Bio-Strategic Directors, providing consulting services to the life sciences industry.
He is a director of Resolve Therapeutics, and a research committee member of the American Society of Clinical Oncology.
InB is the developer of a platform technology intended to manufacture biopharmaceuticals quickly and efficiently. The company has established an exclusive commercial relationship with the Fraunhofer USA Center for Molecular Biotechnology; lead product candidates from their joint program include influenza vaccines and an antiviral therapeutic for treatment of influenza.
Richards Barry Joyce & Partners Names New Member for its Cambridge Leasing Team
Thomas Smith has been named an associate broker with the Cambridge leasing group of Boston-based Richards Barry Joyce & Partners, a full-service commercial real estate advisory firm. Smith will be responsible for tenant and landlord representation in Cambridge and the greater Boston suburbs.
Previously, Smith worked for the home healthcare company Praxair Healthcare, and also worked in commercial real estate for Equis Corporation, where his primary responsibilities included new business development, financial analysis and benchmarking.
Smith earned a BA from the University of Massachusetts Amherst.
NuPathe CEO Scores WIN with Award from Women’s Entrepreneurship Group
Jane Holmes Hollingsworth, co-founder and CEO of NuPathe, received this year's Iris Newman Award from Women Inventing Next or WIN, a greater Philadelphia organization for women business leaders and supporters. NuPathe is a pharmaceutical company focused on developing products for neurological and psychiatric diseases.
The Iris Newman award is presented annually by WIN to a woman business leader in the Greater Philadelphia area who has demonstrated an outstanding commitment to helping advance women entrepreneurs. Hollingsworth received the award at Win's annual celebration, held Nov. 14 at the Rittenhouse Hotel in Philadelphia.
Prior to NuPathe, Hollingsworth was a co-founder and officer of Auxilium Pharmaceuticals, and served as its general counsel. Earlier she was vice president, secretary and general counsel of IBAH, a publicly-traded, multinational contract research organization sold to Omnicare in 1998.
Hollingsworth graduated from Villanova (Pa.) University School of Law, and from Gettysburg (Pa.) College.
Empire State Development Taps Real Estate Executive for Business Development Post
Michael Oates has been named Westchester County, NY, director of business development for the Empire State Development Corporation, New York state’s economic development agency.
Oates will oversee ESD’s job attraction and retention efforts in Westchester, assist businesses seeking state, local and federal incentives, help structure financial incentive packages and manage ESD’s relationships with elected officials, community and business groups, universities and nonprofits.
Oates previously was executive vice president of Prudential Rand Realty, a residential and commercial real estate firm based in White Plains, NY. Earlier he was president of a residential construction company. Oates lives in South Salem, NY.